Literature DB >> 16766521

The corticotropin-releasing factor receptor type 2a contains an N-terminal pseudo signal peptide.

Claudia Rutz1, Armin Renner, Martina Alken, Katharina Schulz, Michael Beyermann, Burkhard Wiesner, Walter Rosenthal, Ralf Schülein.   

Abstract

The corticotropin-releasing factor receptor type 2a (CRF(2(a)) receptor) belongs to the family of G protein-coupled receptors. The receptor possesses a putative N-terminal signal peptide that is believed to be cleaved-off after mediating the endoplasmic reticulum targeting/insertion process, like the corresponding sequence of the homologous CRF(1) receptor. Here, we have assessed the functional significance of the putative signal peptide of the CRF(2(a)) receptor and show that it is surprisingly completely incapable of mediating endoplasmic reticulum targeting, despite meeting all sequence criteria for a functional signal by prediction algorithms. Moreover, it is uncleaved and forms part of the mature receptor protein. Replacement of residue Asn(13) by hydrophobic or positively charged residues converts the sequence into a fully functional and cleaved signal peptide demonstrating that conventional signal peptide functions are inhibited by a single amino acid residue. Deletion of the domain leads to an increase in the amount of immature, intracellularly retained receptors demonstrating that the sequence has adopted a new function in receptor trafficking through the early secretory pathway. Taken together, our results identify a novel hydrophobic receptor domain in the family of the heptahelical G protein-coupled receptors and the first pseudo signal peptide of a eukaryotic membrane protein. Our data also show that the extreme N termini of the individual CRF receptor subtypes differ substantially.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766521     DOI: 10.1074/jbc.M601554200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization.

Authors:  Anke Teichmann; Claudia Rutz; Annika Kreuchwig; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

2.  The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity.

Authors:  Katharina Schulz; Claudia Rutz; Carolin Westendorf; Ingrid Ridelis; Susanne Vogelbein; Jens Furkert; Antje Schmidt; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Fine-mapping and comprehensive transcript analysis reveals nonsynonymous variants within a novel 1.17 Mb blood pressure QTL region on rat chromosome 10.

Authors:  Yasser Saad; Michael R Garrett; Ezhilarasi Manickavasagam; Shane Yerga-Woolwine; Phyllis Farms; Tracy Radecki; Bina Joe
Journal:  Genomics       Date:  2007-01-10       Impact factor: 5.736

Review 4.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

5.  The specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulum.

Authors:  Anke Teichmann; Arthur Gibert; André Lampe; Paul Grzesik; Claudia Rutz; Jens Furkert; Jan Schmoranzer; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

6.  GluA1 signal peptide determines the spatial assembly of heteromeric AMPA receptors.

Authors:  Xue-Yan He; Yan-Jun Li; Chakrapani Kalyanaraman; Li-Li Qiu; Chen Chen; Qi Xiao; Wen-Xue Liu; Wei Zhang; Jian-Jun Yang; Guiquan Chen; Matthew P Jacobson; Yun Stone Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

7.  Inhibition of biosynthesis of human endothelin B receptor by the cyclodepsipeptide cotransin.

Authors:  Carolin Westendorf; Antje Schmidt; Irene Coin; Jens Furkert; Ingrid Ridelis; Dimitris Zampatis; Claudia Rutz; Burkhard Wiesner; Walter Rosenthal; Michael Beyermann; Ralf Schülein
Journal:  J Biol Chem       Date:  2011-07-30       Impact factor: 5.157

8.  Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor.

Authors:  Y Huang; G F Wilkinson; Gary B Willars
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

9.  Cellular adaptations of dorsal raphe serotonin neurons associated with the development of active coping in response to social stress.

Authors:  Susan K Wood; Xiao-Yan Zhang; Beverly A S Reyes; Catherine S Lee; Elisabeth J Van Bockstaele; Rita J Valentino
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

10.  Intact signal peptide of CD18, the beta-subunit of beta2-integrins, renders ruminants susceptible to Mannheimia haemolytica leukotoxin.

Authors:  Sudarvili Shanthalingam; Subramaniam Srikumaran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.